Publications in collaboration with researchers from University of Toronto (8)

2023

  1. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors

    Molecular Cancer, Vol. 22, Núm. 1

  2. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations

    The Lancet Oncology, Vol. 24, Núm. 4, pp. e172-e185

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer: Results from the multicohort phase II FINESSE study

    Clinical Cancer Research, Vol. 26, Núm. 2, pp. 354-363

2019

  1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study

    Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404

2015

  1. A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

    British Journal of Cancer, Vol. 112, Núm. 4, pp. 650-659

2014

  1. A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

    Breast, Vol. 23, Núm. 5, pp. 656-662

2012

  1. Safety of bevacizumab in metastatic breast cancer patients undergoing surgery

    European Journal of Cancer, Vol. 48, Núm. 4, pp. 475-481